• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Annexon, Inc. - common stock (NQ:ANNX)

    5.515 -0.025 (-0.45%)
    Streaming Delayed Price Updated: 1:51 PM EDT, Apr 1, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,366,731
    Open 5.680
    Bid (Size) 5.520 (100)
    Ask (Size) 5.530 (400)
    Prev. Close 5.540
    Today's Range 5.510 - 5.990
    52wk Range 1.285 - 7.180
    Shares Outstanding 47,722,995
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Biogen Acquires Apellis Pharmaceuticals in $5.6 Billion Deal After Clinical Success
    In a move that has sent shockwaves through the biotechnology sector, Apellis Pharmaceuticals (Nasdaq: APLS) witnessed an extraordinary 135.7% surge in its share price on March 31, 2026. The massive... 
    Via MarketMinute
    News headline image
    Annexon Reports Fourth Quarter and Year-End 2025 Financial Results, Portfolio Progress and Key Anticipated Milestones
    From Annexon Biosciences
    Via GlobeNewswire

    Performance

    YTD
    +17.6%
    +17.6%
    1 Month
    -0.1%
    -0.1%
    3 Month
    +9.4%
    +9.4%
    6 Month
    +80.8%
    +80.8%
    1 Year
    +185.8%
    +185.8%

    More News

    Read More
    News headline image
    Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)
    From Annexon Biosciences
    Via GlobeNewswire
    News headline image
    Annexon Biosciences to Present at the TD Cowen 46th Annual Health Care Conference
    From Annexon Biosciences
    Via GlobeNewswire
    News headline image
    Annexon to Host In-Person and Virtual KOL Event to Discuss Vonaprument for the Treatment of Geographic Atrophy
    From Annexon Biosciences
    Via GlobeNewswire
    News headline image
    Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
    From Annexon Biosciences
    Via GlobeNewswire
    Curious about the stocks that are showing activity after the closing bell on Monday? ↗
    Via Chartmill
    News headline image
    Annexon Accelerating Next Generation Targeted Immunotherapy Platform for Treatment of Neuroinflammatory Diseases with Multiple Registrational Milestones in 2026
    From Annexon Biosciences
    Via GlobeNewswire
    News headline image
    Annexon Submits Tanruprubart Marketing Authorization Application to the European Medicines Agency for Guillain-Barré Syndrome
    From Annexon Biosciences
    Via GlobeNewswire
    News headline image
    Annexon Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference
    From Annexon Biosciences
    Via GlobeNewswire
    News headline image
    Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)
    From Annexon Biosciences
    Via GlobeNewswire
    News headline image
    Which stocks are moving on Wednesday? ↗
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Friday's After-Market Session ↗
    Via Benzinga
    News headline image
    Annexon Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $86.25 Million
    From Annexon Biosciences
    Via GlobeNewswire
    News headline image
    Annexon Announces Pricing of $75 Million Public Offering of Common Stock and Pre-Funded Warrants
    From Annexon Biosciences
    Via GlobeNewswire
    News headline image
    Annexon Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
    From Annexon Biosciences
    Via GlobeNewswire
    News headline image
    Annexon Reports Third Quarter 2025 Financial Results, Portfolio Progress and Key Anticipated Milestones
    From Annexon Biosciences
    Via GlobeNewswire
    News headline image
    Annexon Biosciences to Participate in Upcoming September Investor Conferences
    From Annexon Biosciences
    Via GlobeNewswire
    News headline image
    Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)
    From Annexon Biosciences
    Via GlobeNewswire
    News headline image
    Annexon Narrows Loss in Fiscal Q2 ↗
    Via The Motley Fool
    Topics Intellectual Property
    News headline image
    Annexon Reports Second Quarter 2025 Financial Results, Portfolio Progress and Key Anticipated Milestones
    From Annexon Biosciences
    Via GlobeNewswire
    News headline image
    Annexon Selected by EMA to Participate in Product Development Coordinator Pilot for Vonaprument (ANX007) for Dry Age-Related Macular Degeneration with Geographic Atrophy
    From Annexon Biosciences
    Via GlobeNewswire
    News headline image
    Annexon Announces Completion of Enrollment in Pivotal Phase 3 ARCHER II Trial of Vonaprument (formerly ANX007) for Dry Age-Related Macular Degeneration (AMD) with Geographic Atrophy
    From Annexon Biosciences
    Via GlobeNewswire
    News headline image
    Thursday's session: gap up and gap down stocks ↗
    Via Chartmill

    Frequently Asked Questions

    Is Annexon, Inc. - common stock publicly traded?
    Yes, Annexon, Inc. - common stock is publicly traded.
    What exchange does Annexon, Inc. - common stock trade on?
    Annexon, Inc. - common stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Annexon, Inc. - common stock?
    The ticker symbol for Annexon, Inc. - common stock is ANNX on the Nasdaq Stock Market
    What is the current price of Annexon, Inc. - common stock?
    The current price of Annexon, Inc. - common stock is 5.515
    When was Annexon, Inc. - common stock last traded?
    The last trade of Annexon, Inc. - common stock was at 04/01/26 01:51 PM ET
    What is the market capitalization of Annexon, Inc. - common stock?
    The market capitalization of Annexon, Inc. - common stock is 263.19M
    How many shares of Annexon, Inc. - common stock are outstanding?
    Annexon, Inc. - common stock has 263M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.